Prescription Opioid Abuse in the Emergency Department

Joranson D. E. Ryan K. M. Gilson A. M. Dahl J. L. , “Trends in Medical Use and Abuse of Opioid Analgesics,” JAMA 283, no. 13 (2000): 1710–1714.

Nonmedical Use of Prescription Pain Relievers, available at <http://www.oas.samhsa.gov/2k4/pain/pain.htm> (last visited October 11, 2005).

The President's National Drug Control Strategy 2004, available at <http://www.whitehousedrugpolicy.gov/publications/policy/ndcs04/2004ndcs.pdf> (last visited October 11, 2005).

DEA, Department of Justice, Last Acts Partnership, “Pain & Policies Study Group at the University of Wisconsin Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals, and Law Enforcement Personnel,” Journal of Pain, Palliative Care and Pharmacotherapy 19, no. 1 (2005): 71–104.

Tamayo-Sarver J. H. Dawson N. V. Cydulka R. K. Wigton R. S. Baker D. W. , “Variability in Emergency Physician Decision Making about Prescribing Opioid Analgesics,” Annals of Emergency Medicine 43, no. 4 (2004): 483–493.

Galanter M. Castaneda R. Ferman J. , “Substance Abuse among General Psychiatric Patients: Place of Presentation, Diagnosis, and Treatment,” American Journal of Drug and Alcohol Abuse 14, no. 2 (1988): 211–235.

Michna E. Ross E. L. Hynes W. L. , “Predicting Aberrant Drug Behavior in Patients Treated for Chronic Pain: Importance of Abuse History,” Journal of Pain and Symptom Management 28, no. 3 (2004): 250–258. Reid M. C. Engles-Horton L. L. Weber M. B. Kerns R. D. Rogers E. L. O'Connor P. G. , “Use of Opioid Medications for Chronic Noncancer Pain Syndromes in Primary Care,” Journal of General Internal Medicine 17, no. 3 (2002): 173–179

MacLeod D. B. Swanson R. , “A New Approach to Chronic Pain in the ED,” American Journal of Emergency Medicine 14, no. 3 (1996): 323–326.

Cherpitel C. J. Borges G. , “Screening for Drug Use Disorders in the Emergency Department: Performance of the Rapid Drug Problems Screen (RDPS),” Drug Alcohol Dependency 74, no. 2 (2004): 171–175; Cherpitel C. J. Borges G. , “Performance of Screening Instruments for Alcohol Problems in the ER: A Comparison of Mexican-Americans and Mexicans in Mexico,” American Journal of Drug and Alcohol Abuse 26, no. 4 (2000): 683–702.

Portenoy R. Payne R. , “Acute and Chronic Pain,” in Lowinson J. Ruiz P. Millman R. Langrod J. eds., Substance Abuse: A Comprehensive Textbook (Baltimore: Williams & Wilkins, 1997): 563–590; Jaffe J. , “Opiates: Clinical Aspects,” in Lowinson J. Ruiz P. Millman R. E. , eds., Substance Abuse: A Comprehensive Text (Baltimore: Williams & Wilkins, 1992): 186–194.

Chabal C. Erjavec M. K. Jacobson L. Mariano A. Chaney E. , “Prescription Opiate Abuse in Chronic Pain Patients: Clinical Criteria, Incidence, and Predictors,” Clinical Journal of Pain 13, no. 2 (1997): 150–155.

Katz N. P. Sherburne S. Beach M. , “Behavioral Monitoring and Urine Toxicology Testing in Patients Receiving Long-Term Opioid Therapy,” Anesthesia and Analgesia 97, no. 4 (2003): 1097–1102, table of contents.

Compton P. Darakjian J. Miotto K. , “Screening for Addiction in Patients with Chronic Pain and “Problematic” Substance Use: Evaluation of a Pilot Assessment Tool,” Journal of Pain and Symptom Management 16, no. 6 (1998): 355–363.

Adams L. L. Gatchel R. J. Robinson R. C. , “Development of a Self-Report Screening Instrument for Assessing Potential Opioid Medication Misuse in Chronic Pain Patients,” Journal of Pain and Symptom Management 27, no. 5 (2004): 440–459.

Butler S. F. Budman S. H. Fernandez K. Jamison R. N. , “Validation of a Screener and Opioid Assessment Measure for Patients with Chronic Pain,” Pain 112, no. 1–2 (2004): 65–75.

Compton P. Darakjian J. Miotto K. , “Screening for Addiction in Patients with Chronic Pain and Problematic Substance Use: Evaluation of a Pilot Assessment Tool,” Journal of Pain and Symptom Management 16, no. 6 (1998): 355–363.

Passik S. D. Kirsh K. L. Whitcomb L. , “A New Tool to Assess and Document Pain Outcomes in Chronic Pain Patients Receiving Opioid Therapy,” Clinical Therapeutics 26, no. 4 (2004): 552–561.

NIDA, “Research Report Series - Prescription Drugs: Abuse and Addiction,” available at <http://www.drugabuse.gov/ResearchReports/Prescription/prescription6.html> (last visited October 12, 2005).

Ewing J. A. , “Detecting Alcoholism. The CAGE Questionnaire,” JAMA 252, no. 14 (1984): 1905–1907.

Supra note 7.

Supra note 7.

Schulz J. Parran T. , “Principles of identification and intervention,” in Graham A. W. Wilford B. B. 2d eds., Principles of Addiction Medicine (Chevy Chase, MD: American Society of Addiction Medicine, 1998): 251.

United States Supreme Court decision in Gonzales v. Raich 125 S.Ct. 2195 (2005).

Perrone J. De Roos F. Jayaraman S. Hollander J. E. , “Drug Screening Versus History in Detection of Substance Use in ED Psychiatric Patients,” American Journal of Emergency Medicine 19, no. 1 (2001): 49–51.

Dunbar S. A. Katz N. P. , “Chronic Opioid Therapy for Nonmalignant Pain in Patients with a History of Substance Abuse: Report of 20 Cases,” Journal of Pain and Symptom Management 11, no. 3 (1996): 163–171.

Savage S. , “Management of Acute Pain, Chronic Pain and Cancer Pain in the Addicted Patient,” in Miller N. , ed., Principles of Addiction Medicine Vol. Sec. VIII (Chevy Chase, MD: American Society of Addiction Medicine, 1994): 4.

American Society of Addiction Medicine Patient Placement Criteria for the Treatment of Substance-Related Disorders 2005, available at <http://www.stpetershealthcare.org/addiction/SPBHM_ASAM_Criteria.pdf> (last visited October 12, 2005).

Nolimal D. Crowley T. J. , “Difficulties in a Clinical Application of Methadone-dose Contingency Contracting,” Journal of Substance Abuse and Treatment 7, no. 4 (1990): 219–224.

Saxon A. J. Calsyn D. A. Kivlahan D. R. Roszell D. K. , “Outcome of Contingency Contracting for Illicit Drug Use in a Methadone Maintenance Program,” Drug and Alcohol Dependency 31, no. 3 (1993): 205–214.

Burchman S. L. Pagel P. S. , “Implementation of a Formal Treatment Agreement for Outpatient Management of Chronic Nonmalignant Pain with Opioid Analgesics,” Journal of Pain and Symptom Management 10, no. 7 (1995): 556–563.

Fishman S. M. Bandman T. B. Edwards A. Borsook D. , “The Opioid Contract in the Management of Chronic Pain,” Journal of Pain and Symptom Management 18, no. 1 (1999): 27–37.

Fisher D. M. Kellett N. Lenhardt R. , “Pharmacokinetics of an Implanted Osmotic Pump Delivering Sufentanil for the Treatment of Chronic Pain,” Anesthesiology 99, no. 4. (2003): 929–937.

Geller D. E. , “New Liquid Aerosol Generation Devices: Systems that Force Pressurized Liquids through Nozzles,” Respiratory Care 47, no. 12 (2002): 1392–1404; discussion 1404–1395.

Mystakidou K. , “E-TRANS fentanyl, ALZA,” Current Opinions Investigational Drugs 3, no. 3 (2002): 463–469, at 35. Palangio M. Northfelt D. W. Portenoy R. K. , “Dose Conversion and Titration with a Novel, Once-Daily, OROS Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain,” Journal of Pain and Symptom Management 23, no. 5 (2002): 355–368.

Thomsen A. B. Becker N. Eriksen J. , “Opioid Rotation In Chronic Non-Malignant Pain Patients. A Retrospective Study,” Acta Anaesthesia Scandinavia 43, no. 9 (1999): 918–923.

Chou R. Clark E. Helfand M. , “Comparative Efficacy and Safety of Long-Acting Oral Opioids for Chronic Non-Cancer Pain: A Systematic Review,” Journal of Pain and Symptom Management 26, no. 5 (2003): 1026–1048.

Heit H. A. , “The Truth about Pain Management: The Difference Between a Pain Patient and an Addicted Patient,” European Journal of Pain 5 (2001): 5, Supplement A27–29, 40; McCarberg B. H. Barkin R. L. , “Long-Acting Opioids for Chronic Pain: Pharmacotherapeutic Opportunities to Enhance Compliance, Quality of Life, and Analgesia,” American Journal of Therapeutics 8, no. 3 (2001): 181–186.

Clark J. D. , “Chronic Pain Prevalence and Analgesic Prescribing in a General Medical Population,” Journal of Pain and Symptom Management 23, no. 2 (2002): 131–137.

Watkins A. Wasmann S. Dodson L. Hayes M. , “An Evaluation of the Care Provided to Patients Prescribed Controlled Substances for Chronic Nonmalignant Pain at an Academic Family Medicine Center,” Family Medicine 36, no. 7 (2004): 487–489.

Material Risk Notice, “Oregon Board of Medical Examiners,” available at <http://www.oregon.gov/BME/PDFforms/MaterialRiskNotice.pdf> (last visited October 12, 2005).

Supra note 39.

Geiderman J. M. , “Keeping Lists and Naming Names: Habitual Patient Files for Suspected Nontherapeutic Drug-Seeking Patients,” Annals of Emergency Medicine 41, no. 6 (2003): 873–881.

Moskop J. C. Marco C. A. Larkin G. L. Geiderman J. M. Derse A. R. , “From Hippocrates to HIPAA: Privacy and Confidentiality in Emergency Medicine - Part II: Challenges in the Emergency Department,” Annals of Emergency Medicine 45, no 1 (2005): 60–67.

Fishman S. M. Wilsey B. Mahajan G. Molina P. , “Methadone Reincarnated: Novel Clinical Applications with Related Concerns,” Pain and Medicine 3, no. 4 (2002): 339–348.

National All Schedules Prescription Electronic Reporting Act of 2005, available at <http://www.govtrack.us/data/us/bills.text/109/h1132.pdf> (last visited October 12, 2005).

Wilsey B. Fishman S. Rose J. S. Papazian J. , “Pain management in the ED,” American Journal of Emergency Medicine 22, no. 1 (2004): 51–57.

Jaffe , supra note 10.

Chabal C. Erjavec M. K. Jacobson L. Mariano A. Chaney E. , “Prescription Opiate Abuse in Chronic Pain Patients: Clinical Criteria, Incidence, and Predictors,” Clinical Journal of Pain 13, no. 2 (1997): 150–155.

Compton P. , etc., supra note 13.

NIDA, supra note 18.

Reid M. C. , etc., supra note 7.